Cargando…
Skin Dosimetry with EBT3 Radiochromic Film in Radiotherapy of Parotid Cancer
BACKGROUND: Skin is a sensitive organ and should be spared in radiotherapy and irradiation of skin in radiotherapy can cause to acute and late skin effects such as erythema, desquamation, epilation, color change, or even necrosis. OBJECTIVE: The aim of the present study is to do skin dosimetry in ra...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shiraz University of Medical Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546163/ https://www.ncbi.nlm.nih.gov/pubmed/34722402 http://dx.doi.org/10.31661/jbpe.v0i0.1083 |
_version_ | 1784590134450061312 |
---|---|
author | Bahreyni Toossi, Mohammad Taghi Ghorbani, Mahdi Khorshidi, Farideh Mohammadi, Mohammad Mohamadian, Nastaran Akbari, Fateme Dayani, Mahdie |
author_facet | Bahreyni Toossi, Mohammad Taghi Ghorbani, Mahdi Khorshidi, Farideh Mohammadi, Mohammad Mohamadian, Nastaran Akbari, Fateme Dayani, Mahdie |
author_sort | Bahreyni Toossi, Mohammad Taghi |
collection | PubMed |
description | BACKGROUND: Skin is a sensitive organ and should be spared in radiotherapy and irradiation of skin in radiotherapy can cause to acute and late skin effects such as erythema, desquamation, epilation, color change, or even necrosis. OBJECTIVE: The aim of the present study is to do skin dosimetry in radiotherapy of parotid cancer using Gafchromic EBT3 radiochromic film. EBT3 radiochromic films were calibrated in 0.2-5 Gy dose range. MATERIAL AND METHODS: This is an experimental study in the field of radiotherapy physics. Treatment planning was performed on a RANDO phantom for treatment of parotid cancer by a clinical oncologist. Based on the treatment planning, the skin dose at various points in the overlapping region of right anterior-oblique and right posterior-oblique fields were measured using EBT3 radiochromic film. RESULTS: The minimum and maximum skin doses in a fraction (with 2.0 Gy prescribed dose) were 0.50 Gy and 0.97 Gy, respectively. Based on these values, the total skin dose in 30 treatment fractions (for removed tumor) or in 35 treatment fractions (for unremoved tumor) was in the range of 15-33 Gy. CONCLUSION: Based on the skin dosimetry results of parotid cancer radiotherapy using EBT3 films, it is predicted that there will occur mild skin reactions and these reactions can be neglected due to being mild. |
format | Online Article Text |
id | pubmed-8546163 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Shiraz University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-85461632021-10-29 Skin Dosimetry with EBT3 Radiochromic Film in Radiotherapy of Parotid Cancer Bahreyni Toossi, Mohammad Taghi Ghorbani, Mahdi Khorshidi, Farideh Mohammadi, Mohammad Mohamadian, Nastaran Akbari, Fateme Dayani, Mahdie J Biomed Phys Eng Original Article BACKGROUND: Skin is a sensitive organ and should be spared in radiotherapy and irradiation of skin in radiotherapy can cause to acute and late skin effects such as erythema, desquamation, epilation, color change, or even necrosis. OBJECTIVE: The aim of the present study is to do skin dosimetry in radiotherapy of parotid cancer using Gafchromic EBT3 radiochromic film. EBT3 radiochromic films were calibrated in 0.2-5 Gy dose range. MATERIAL AND METHODS: This is an experimental study in the field of radiotherapy physics. Treatment planning was performed on a RANDO phantom for treatment of parotid cancer by a clinical oncologist. Based on the treatment planning, the skin dose at various points in the overlapping region of right anterior-oblique and right posterior-oblique fields were measured using EBT3 radiochromic film. RESULTS: The minimum and maximum skin doses in a fraction (with 2.0 Gy prescribed dose) were 0.50 Gy and 0.97 Gy, respectively. Based on these values, the total skin dose in 30 treatment fractions (for removed tumor) or in 35 treatment fractions (for unremoved tumor) was in the range of 15-33 Gy. CONCLUSION: Based on the skin dosimetry results of parotid cancer radiotherapy using EBT3 films, it is predicted that there will occur mild skin reactions and these reactions can be neglected due to being mild. Shiraz University of Medical Sciences 2021-10-01 /pmc/articles/PMC8546163/ /pubmed/34722402 http://dx.doi.org/10.31661/jbpe.v0i0.1083 Text en Copyright: © Journal of Biomedical Physics and Engineering https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 Unported License, ( http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Bahreyni Toossi, Mohammad Taghi Ghorbani, Mahdi Khorshidi, Farideh Mohammadi, Mohammad Mohamadian, Nastaran Akbari, Fateme Dayani, Mahdie Skin Dosimetry with EBT3 Radiochromic Film in Radiotherapy of Parotid Cancer |
title | Skin Dosimetry with EBT3 Radiochromic Film in Radiotherapy of Parotid Cancer |
title_full | Skin Dosimetry with EBT3 Radiochromic Film in Radiotherapy of Parotid Cancer |
title_fullStr | Skin Dosimetry with EBT3 Radiochromic Film in Radiotherapy of Parotid Cancer |
title_full_unstemmed | Skin Dosimetry with EBT3 Radiochromic Film in Radiotherapy of Parotid Cancer |
title_short | Skin Dosimetry with EBT3 Radiochromic Film in Radiotherapy of Parotid Cancer |
title_sort | skin dosimetry with ebt3 radiochromic film in radiotherapy of parotid cancer |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546163/ https://www.ncbi.nlm.nih.gov/pubmed/34722402 http://dx.doi.org/10.31661/jbpe.v0i0.1083 |
work_keys_str_mv | AT bahreynitoossimohammadtaghi skindosimetrywithebt3radiochromicfilminradiotherapyofparotidcancer AT ghorbanimahdi skindosimetrywithebt3radiochromicfilminradiotherapyofparotidcancer AT khorshidifarideh skindosimetrywithebt3radiochromicfilminradiotherapyofparotidcancer AT mohammadimohammad skindosimetrywithebt3radiochromicfilminradiotherapyofparotidcancer AT mohamadiannastaran skindosimetrywithebt3radiochromicfilminradiotherapyofparotidcancer AT akbarifateme skindosimetrywithebt3radiochromicfilminradiotherapyofparotidcancer AT dayanimahdie skindosimetrywithebt3radiochromicfilminradiotherapyofparotidcancer |